Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021
Throughout the COVID-19 pandemic, older U.S. adults have been at increased risk for severe COVID-19-associated illness and death (1). On December 14, 2020, the United States began a nationwide vaccination campaign after the Food and Drug Administration's Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine. The Advisory Committee on Immunization Practices (ACIP) recommended prioritizing health care personnel and residents of long-term care facilities, followed by essential workers and persons at risk for severe illness, including adults aged ≥65 years, in the early phases of the vaccination program (2). By May 1, 2021, 82%, 63%, and 42% of persons aged ≥65, 50-64, and 18-49 years, respectively, had received ≥1 COVID-19 vaccine dose. CDC calculated the rates of COVID-19 cases, emergency department (ED) visits, hospital admissions, and deaths by age group during November 29-December 12, 2020 (prevaccine) and April 18-May 1, 2021. The rate ratios comparing the oldest age groups (≥70 years for hospital admissions; ≥65 years for other measures) with adults aged 18-49 years were 40%, 59%, 65%, and 66% lower, respectively, in the latter period. These differential declines are likely due, in part, to higher COVID-19 vaccination coverage among older adults, highlighting the potential benefits of rapidly increasing vaccination coverage.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:70 |
---|---|
Enthalten in: |
MMWR. Morbidity and mortality weekly report - 70(2021), 23 vom: 11. Juni, Seite 858-864 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Christie, Athalia [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.06.2021 Date Revised 22.06.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.15585/mmwr.mm7023e2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326590382 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326590382 | ||
003 | DE-627 | ||
005 | 20231225194925.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.15585/mmwr.mm7023e2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1088.xml |
035 | |a (DE-627)NLM326590382 | ||
035 | |a (NLM)34111059 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Christie, Athalia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.06.2021 | ||
500 | |a Date Revised 22.06.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Throughout the COVID-19 pandemic, older U.S. adults have been at increased risk for severe COVID-19-associated illness and death (1). On December 14, 2020, the United States began a nationwide vaccination campaign after the Food and Drug Administration's Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine. The Advisory Committee on Immunization Practices (ACIP) recommended prioritizing health care personnel and residents of long-term care facilities, followed by essential workers and persons at risk for severe illness, including adults aged ≥65 years, in the early phases of the vaccination program (2). By May 1, 2021, 82%, 63%, and 42% of persons aged ≥65, 50-64, and 18-49 years, respectively, had received ≥1 COVID-19 vaccine dose. CDC calculated the rates of COVID-19 cases, emergency department (ED) visits, hospital admissions, and deaths by age group during November 29-December 12, 2020 (prevaccine) and April 18-May 1, 2021. The rate ratios comparing the oldest age groups (≥70 years for hospital admissions; ≥65 years for other measures) with adults aged 18-49 years were 40%, 59%, 65%, and 66% lower, respectively, in the latter period. These differential declines are likely due, in part, to higher COVID-19 vaccination coverage among older adults, highlighting the potential benefits of rapidly increasing vaccination coverage | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Henley, S Jane |e verfasserin |4 aut | |
700 | 1 | |a Mattocks, Linda |e verfasserin |4 aut | |
700 | 1 | |a Fernando, Robyn |e verfasserin |4 aut | |
700 | 1 | |a Lansky, Amy |e verfasserin |4 aut | |
700 | 1 | |a Ahmad, Farida B |e verfasserin |4 aut | |
700 | 1 | |a Adjemian, Jennifer |e verfasserin |4 aut | |
700 | 1 | |a Anderson, Robert N |e verfasserin |4 aut | |
700 | 1 | |a Binder, Alison M |e verfasserin |4 aut | |
700 | 1 | |a Carey, Kelly |e verfasserin |4 aut | |
700 | 1 | |a Dee, Deborah L |e verfasserin |4 aut | |
700 | 1 | |a Dias, Taylor |e verfasserin |4 aut | |
700 | 1 | |a Duck, William M |e verfasserin |4 aut | |
700 | 1 | |a Gaughan, Denise M |e verfasserin |4 aut | |
700 | 1 | |a Lyons, Brianna Casey |e verfasserin |4 aut | |
700 | 1 | |a McNaghten, A D |e verfasserin |4 aut | |
700 | 1 | |a Park, Meeyoung M |e verfasserin |4 aut | |
700 | 1 | |a Reses, Hannah |e verfasserin |4 aut | |
700 | 1 | |a Rodgers, Loren |e verfasserin |4 aut | |
700 | 1 | |a Van Santen, Katharina |e verfasserin |4 aut | |
700 | 1 | |a Walker, David |e verfasserin |4 aut | |
700 | 1 | |a Beach, Michael J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t MMWR. Morbidity and mortality weekly report |d 1984 |g 70(2021), 23 vom: 11. Juni, Seite 858-864 |w (DE-627)NLM012594334 |x 1545-861X |7 nnns |
773 | 1 | 8 | |g volume:70 |g year:2021 |g number:23 |g day:11 |g month:06 |g pages:858-864 |
856 | 4 | 0 | |u http://dx.doi.org/10.15585/mmwr.mm7023e2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 70 |j 2021 |e 23 |b 11 |c 06 |h 858-864 |